End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.03 CNY | +0.50% | -2.66% | -29.17% |
Apr. 18 | Guizhou Yibai Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
2023 | YiBai Pharma to Repurchase Up to 40 Million Yuan Shares | MT |
Sales 2022 | 2.74B 377M | Sales 2023 | 2.82B 389M | Capitalization | 4.51B 622M |
---|---|---|---|---|---|
Net income 2022 | -426M -58.79M | Net income 2023 | 103M 14.21M | EV / Sales 2022 | 1.78 x |
Net Debt 2022 | 495M 68.26M | Net Debt 2023 | 301M 41.5M | EV / Sales 2023 | 1.7 x |
P/E ratio 2022 |
-10.3
x | P/E ratio 2023 |
43.4
x | Employees | 5,509 |
Yield 2022 * |
-
| Yield 2023 |
1.16% | Free-Float | 68.48% |
1 day | +0.50% | ||
1 week | -2.66% | ||
Current month | -15.16% | ||
1 month | -14.07% | ||
3 months | -21.90% | ||
6 months | -26.99% | ||
Current year | -29.17% |
Managers | Title | Age | Since |
---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 40 | 08-04-30 |
Xian Hong Jiang
DFI | Director of Finance/CFO | 39 | 20-03-22 |
Zhi Wei Wang
BRD | Director/Board Member | 54 | 11-02-20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Qi Ling Dou
FOU | Founder | 64 | 95-05-31 |
Zhi Wei Wang
BRD | Director/Board Member | 54 | 11-02-20 |
Ya Qi Dou
CEO | Chief Executive Officer | 40 | 08-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 4.03 | +0.50% | 9 828 385 |
24-04-25 | 4.01 | +0.75% | 10,820,800 |
24-04-24 | 3.98 | -0.50% | 10,246,290 |
24-04-23 | 4 | +2.83% | 16,140,670 |
24-04-22 | 3.89 | 0.00% | 20,384,920 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-29.17% | 438M | |
+25.97% | 653B | |
+27.00% | 556B | |
-6.56% | 354B | |
+20.40% | 331B | |
+2.80% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.36% | 144B |
- Stock Market
- Equities
- 600594 Stock